Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The relative activities among ACPC-containing analogues of the two natural GLP-1R agonists were consistent with predictions of our hypothesis: the Gly10( R,R )-ACPC analogue of GLP-1 was ~9-fold more potent than the ( S,S )-ACPC diastereomer, and the Gly4( R,R )-ACPC analogue of exendin-4 was ~5-fold more potent than the ( S,S )-ACPC diastereomer in eliciting cAMP production (Fig
As a result, Lexaria is evaluating three of the most important GLP-1 agonist drugs in the market, semaglutide, liraglutide and tirzepatide
Anerillas et al
A new Australian meta-analysis of more than 85,000 patients, including those with and without diabetes, found GLP-1 receptor agonists reduced the risk of kidney failure by 16%, and the worsening of kidney function by 22%
Type2 Diabetes Mellitus(T2DM) is associated with Obesity, Dyslipidemia, and Hypertension
